|
Apr 17
|
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
|
|
Apr 17
|
EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity
|
|
Mar 3
|
Ligand to Participate in March Investor Conferences
|
|
Mar 3
|
LGND: First Steps into Cell & Gene Therapy
|
|
Feb 28
|
Ligand Pharmaceuticals Inc (LGND) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Feb 27
|
Ligand: Q4 Earnings Snapshot
|
|
Feb 27
|
Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 25
|
Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences
|
|
Feb 13
|
Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
|
|
Feb 6
|
Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
|